Monograph
C07AA03 - Pindolol |
Propably not porphyrinogenic |
PNP |
Rationale
Beta-blocker. Clinical experience and wo references point to non-porphyrinogenicity.
Chemical description
Beta-receptor blocking agent used in hypertonia, angina pectoris, tachyarrythmia. Eliminated unchanged (30 -40%) and as metabolites. Thunell, patient reports (n=3): tolerated. Andersson, patient report (n=3): tolerated. South African list: use. EPI: safe (betablockers)
IPNet drug reports
Uneventful use reported in 5 patients with acute porphyria.
Similar drugs
Tradenames
This list comprises raw data collected from different countries.
In some cases, a more comprehensive list of available drug packages is included.
Consequently, very similar terms may therefore appear multiple times.
Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Visken 
Pindolol · Visken 
Visken 
Visken
© NAPOS 2025